Clinical trials: Survival , Tumor
Hepatocellular Carcinoma
A Trial of Licartin for Preventing Tumor Recurrence After Liver Resection
The aim of this study is to analyze the therapeutic effect of adjuvant Licartin therapy after resection.Patients receiving curative resection (R0) were randomized to postoperative Licartin group and no Licartin group.
- Trial name
- NCT00819650
- Testing
- Licartin (generic name,[131I]metuximab injection)
- Where
- China
- Volunteers
- 200 people, healthy volunteers welcome
- Sponsor
- Eastern Hepatobiliary Surgery Hospital
Acute Myeloid Leukemia
Treatment of Acute Leukemia Relapse After Allotransplantation
Patients with relapse of acute leukemia often only receive supportive therapy. Our hypothesis is that a combination therapy can stabilize the disease for patients with early relapse after allogeneic stem cell transplantation.
- Trial name
- NCT01369368
- Testing
- Combined use of azacitidine, valproic acid, hydroxurea and eventually donor leukocyte infusions.
- Where
- Norway
- Volunteers
- 20 people
- Sponsor
- University of Bergen
Prostate Cancer, Quality of Life
Prostate Cancer: Family Care for Patients and Spouses
The purpose of this study is to determine if a family-based intervention (The FOCUS Program) can improve the long-term quality of life and other psycho-social outcomes of men with prostate cancer and their spouses.
- Conditions
- Prostate Cancer, Quality of Life, Cancer Survivorship
- Trial name
- NCT00708968
- Testing
- FOCUS Program
- Where
- 3 sites in United States
- Volunteers
- 263 people
- Sponsor
- University of Michigan
Overall Survival, Tumor Responses
Statin Combination Therapy in Patients Receiving Sorafenib for Advanced Hepatocellular Carcinoma
Target therapy with sorafenib is the standard of treatment for advanced Hepatocellular carcinoma (HCC), but the patient survival time is still unsatisfactory.
- Trial name
- NCT03275376
- Testing
- Atorvastatin 10mg
- Where
- Taiwan
- Volunteers
- 34 people
- Sponsor
- Taichung Veterans General Hospital
Non-small Cell Lung Cancer
A Study on the Long Term Survivals in an Expand Access Program (EAP) of Iressa
The primary objective is to describe the quality of life of long-term survivors who are not terminated from the EAP.
- Trial name
- NCT01000740
- Testing
- EGFR Mutation Test, Ki-67 protein expression
- Where
- 9 sites in China
- Volunteers
- 59 people
- Sponsor
- AstraZeneca
Glioblastoma, IDH-wildtype, Glioblastoma
The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma
Resection of glioblastoma in or near functional brain tissue is challenging because of the proximity of important structures to the tumor site.
- Conditions
- Glioblastoma, IDH-wildtype, Glioblastoma, Glioblastoma Multiforme of Brain, Astrocytoma, Malignant
- Trial name
- RECMAP (NCT06273176)
- Testing
- Awake mapping under local anesthesia, Asleep mapping under general anesthesia, Resection under general anesthesia without mapping
- Where
- 8 sites in United States, Belgium and 3 more
- Volunteers
- 225 people
- Sponsor
- Erasmus Medical Center
Cancer, Insomnia
Survivorship Sleep Program
This is a randomized pilot trial to test the feasibility and acceptability (primary outcomes) of a virtual cognitive behavioral program for insomnia for survivors of various cancer types.
- Trial name
- NCT04566068
- Testing
- Intervention- Adapted Virtual Insomnia Program, Control- Enhanced usual care
- Where
- United States
- Volunteers
- 40 people
- Sponsor
- Massachusetts General Hospital
Endometrial Cancer
Activity and Cancer Survivorship Exercise Pilot
This early phase I clinical trial measures the changes in functional fitness following home-based comprehensive exercise program in patients who have endometrial cancer who have completed treatment.
- Trial name
- NCT07283029
- Testing
- Functional fitness following home-based comprehensive exercise program
- Where
- United States
- Volunteers
- 10 people
- Sponsor
- University of Iowa
Lung Cancer
Survival Outcomes of Lung Cancer
This is a prospective study to analyze the survival outcomes of different groups about lung cancer patients.
- Trial name
- Soul (NCT03647098)
- Testing
- Treatment
- Where
- China
- Volunteers
- 20,000 people
- Sponsor
- Hunan Province Tumor Hospital
Hepatocellular Carcinoma, Liver Transplantation
Liver Transplantation With ADV-TK Gene Therapy Improves Survival in Patients With Advanced Hepatocellular Carcinoma
Previous rather poor results in liver transplantation (LT) of patients with advanced hepatocellular carcinoma (HCC) have made the application of LT very limited in treatment of HCC.
- Trial name
- NCT00300521
- Testing
- ADV-TK (adenovirus-thymidine kinase enzyme) gene therapy
- Where
- China
- Volunteers
- 40 people
- Sponsor
- Beijing Chao Yang Hospital
Breast Cancer Survivors
Cancer Survival Through Weight Loss and Exercise
To test the effectiveness and feasibility of intensive motivational, behavior modifying intervention aimed at improving physical activity and dietary habits to produce at least 7% weight loss in women with a history of breast…
- Trial name
- CASTLE (NCT01217216)
- Testing
- Group-based Intervention, Telephone-based Intervention
- Where
- United States
- Volunteers
- 52 people
- Sponsor
- Pennington Biomedical Research Center
Survivorship, Cancer
mHealth for Young Adult Cancer Survivors
We aim to refine and pilot test an 8-week phone- and app-based intervention to promote hope, and thereby mitigate life disruption caused by cancer diagnosis and treatment, among young adults (YAs); our proposal involves (Aim 1)…
- Conditions
- Survivorship, Cancer, Psychological Well-Being
- Trial name
- mHealthAYA (NCT05905250)
- Testing
- an empirically supported protocol, further refined with evidence-based strategies, Health education
- Where
- United States
- Volunteers
- 155 people
- Sponsor
- George Washington University
Extensive-Stage Small Cell Lung Cancer, Treatment-naïve for Systemic Therapy Targeting Extensive-Stage Small Cell Lung Cancer
Efficacy and Safety of Serplulimab With Chemotherapy and Aspirin in Untreated Extensive-Stage Small Cell Lung Cancer
Lung cancer remains a leading cause of cancer-related deaths worldwide, with small cell lung cancer (SCLC) accounting for 15-20% of all lung cancers.
- Conditions
- Extensive-Stage Small Cell Lung Cancer, Treatment-naïve for Systemic Therapy Targeting Extensive-Stage Small Cell Lung Cancer, ECOG Performance Status Score of 0 or 1, Expected Survival ≥3 Months
- Trial name
- NCT06554535
- Testing
- Serplulimab，Platinum-based Chemotherapy，Aspirin
- Volunteers
- 43 people
- Sponsor
- Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Glioblastoma, Glioblastoma, IDH-wildtype
The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
There are no guidelines or prospective studies defining the optimal surgical treatment for gliomas of older patients (≥70 years) or those with limited functioning performance at presentation (KPS ≤70).
- Conditions
- Glioblastoma, Glioblastoma, IDH-wildtype, Glioblastoma Multiforme, Glioblastoma Multiforme, Adult
- Trial name
- RESBIOP (NCT06146725)
- Testing
- Tumor resection, Tumor biopsy
- Where
- 8 sites in United States, Belgium and 3 more
- Volunteers
- 564 people
- Sponsor
- Jasper Gerritsen
Quality of Life, Cervical Cancer
Comprehensive Study on the Quality of Life in Cervical Cancer Patients
This is prospective cohort study. All the patients with primary cervical cancer in the future three years in Peking Union Medical College Hospital will be included in this study.
- Conditions
- Quality of Life, Cervical Cancer, Urodynamics, Rectum Dynamics
- Trial name
- NCT03967457
- Testing
- questionnaires survey, Urodynamic testing, Rectum dynamics testing
- Where
- China
- Volunteers
- 10,000 people
- Sponsor
- Lei Li
Hepatocellular Carcinoma (HCC), Solitary Mass
Ten-Year Outcomes of Operable Solitary Hepatocellular Carcinoma Patients: Impact of Tumor Size Over 6.5 cm and Microvascular Invasion
The goal of this study is to evaualte the impact of tumor size and microvascular invasion among patients with solitary hepatocellualr carcinoma and post operation.
- Trial name
- NCT06628661
- Testing
- Surgery for HCC larger than 6.5 cm, Surgery for HCC larger than 2 cm
- Where
- Taiwan
- Volunteers
- 3,000 people
- Sponsor
- Chang Gung Memorial Hospital
Lymphocytic Leukemia, Chronic
CLL11: A Study of Obinutuzumab (RO5072759 [GA101]) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia (Stage 1a)
This open-label, randomized, 3-arm study will evaluate the efficacy and safety of obinutuzumab (RO5072759) in combination with chlorambucil as compared to rituximab plus chlorambucil or chlorambucil alone in patients with…
- Trial name
- NCT01010061
- Testing
- obinutuzumab, rituximab, chlorambucil
- Where
- 261 sites in United States, Argentina and 24 more
- Volunteers
- 787 people
- Sponsor
- Hoffmann-La Roche
Childhood Cancer
Childhood Cancer Survivors' Knowledge of Diagnosis,Treatment and Risk of Late Effects: Specialized Survivorship Clinic
This two-part research study will compare childhood cancer survivors receiving specialized follow-up care in the REACH for Survivorship clinic to patients receiving routine follow-up care.
- Trial name
- NCT01223872
- Testing
- interview, clinic visit and interview, interviews and clinic visit
- Where
- United States
- Volunteers
- 188 people
- Sponsor
- Vanderbilt University Medical Center
Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
Feasibility of ONCOhabitats for Surgical and Treatment Planning in IDH-Wildtype Glioblastoma (SINUE)
The goal of this clinical trial is to validate ONCOhabitats, an advanced imaging software, as a medical device for the clinical management of IDH-wildtype glioblastoma.
- Trial name
- SINUE (NCT07111195)
- Testing
- The ONCOhabitats software for MRI-based habitat segmentation
- Where
- 5 sites in Spain
- Volunteers
- 140 people
- Sponsor
- Juan M Garcia-Gomez
Colorectal Cancer, Stage III Colon Cancer
Prognostic Value of the Immunoscore® Colon Test for Disease Free Survival Stratification in Stage III Patients Under Oxaliplatin Treatment
The primary objective is to validate that the Immunoscore® test (IS0 to IS4) is able to identify patients with high risk (IS 0-1) of relapse or death whichever occurs first among Stage III patients under oxaliplatin-based…
- Trial name
- NCT03422601
- Testing
- Immunoscore test
- Where
- France
- Volunteers
- 1,122 people
- Sponsor
- GERCOR - Multidisciplinary Oncology Cooperative Group
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.